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The blood oxygen level dependent 
(BOLD) effect of in‑vitro myoglobin 
and hemoglobin
Dominik P. Guensch1,2*, Matthias C. Michel1, Stefan P. Huettenmoser2, Bernd Jung2, 
Patrik Gulac3,4,5, Adrian Segiser3,4, Sarah L. Longnus3,4 & Kady Fischer1
The presence of deoxygenated hemoglobin (Hb) results in a drop in T2 and T2* in magnetic resonance 
imaging (MRI), known as the blood oxygenation level‑dependent (BOLD‑)effect. The purpose of 
this study was to investigate if deoxygenated myoglobin (Mb) exerts a BOLD‑like effect. Equine 
Met‑Mb powder was dissolved and converted to oxygenated Mb. T1, T2, T2*‑maps and BOLD‑bSSFP 
images at 3Tesla were used to scan 22 Mb samples and 12 Hb samples at room air, deoxygenation, 
reoxygenation and after chemical reduction. In Mb, T2 and T2* mapping showed a significant decrease 
after deoxygenation (− 25% and − 12%, p < 0.01), increase after subsequent reoxygenation (+ 17% and 
0% vs. room air, p < 0.01), and finally a decrease in T2 after chemical reduction (− 28%, p < 0.01). An 
opposite trend was observed with T1 for each stage, while chemical reduction reduced BOLD‑bSSFP 
signal (− 3%, p < 0.01). Similar deflections were seen at oxygenation changes in Hb. The T1 changes 
suggests that the oxygen content has been changed in the specimen. The shortening of transverse 
relaxation times in T2 and T2*‑mapping after deoxygenation in Mb specimens are highly indicative of 
a BOLD‑like effect.
Ogawa et al. first described the utility of sequences exploiting the blood oxygen level-dependent (BOLD) effect in 
brain magnetic resonance imaging (MRI) scans for functional  imaging1. Since then the technique has been used 
extensively for brain  imaging2. In the last 20 years this technique has been adapted and extensively validated in 
cardiovascular magnetic resonance (CMR) studies, mainly to assess (inducible)  ischemia3. However, only more 
recently has this paradigm been used in patient  settings3–7. This so-called BOLD-effect uses deoxygenated hemo-
globin (dHb) as endogenous  contrast2,3. The presence of the paramagnetic dHb results in microscopic magnetic 
field inhomogeneities, which alters the bulk susceptibility of the solvent medium. This will lead to a decrease in 
T2 and moreover T2* relaxation times or a reduction in signal intensity (SI) in sequences sensitive to this BOLD 
effect. Oxygenated Hb  (HbO2) in turn has weak effects on the local magnetic field and has a negligible effect on 
the relaxation times of the bulk water dissolving the molecules. The relative proportion of dHb on the total Hb 
content of the tissue determines T2, T2*, and SI, respectively. Because of its reliance on dHb, BOLD imaging is a 
reflection of the local oxygen supply and demand balance and provides a measure of vascular (dys-)function or 
ischaemia. In in-vivo, the signal attenuation in these images originates in the compartment of the post-capillary 
 venules8. Mechanisms that increase dHb concentration, such as diminished perfusion and oxygen supply or 
increased oxygen extraction and workload attenuate local signal intensity (SI), whereas those reducing relative 
dHb concentration, such as increased blood flow beyond the oxygen demand (luxury-perfusion) will enhance 
SI and produce regional hyper-intensity9. In a healthy system, metabolites indicating increased workload and 
temporary desaturation will initiate a feedback mechanism to increase oxygen supply to maintain the local oxygen 
balance. However, in cases of vascular dysfunction, if an increase in workload and oxygen consumption cannot be 
matched by an increased blood supply, then local deoxygenation occurs consequently reducing BOLD based SI.
Myoglobin (Mb) is a monomeric molecule with a close homology to the alpha and beta sub-units of Hb and 
is ubiquitously found in varying concentrations in most striated muscle fibers and the  myocardium10. Mb has 
a half-saturation pressure  p50 of 2.8  mmHg11, while Hb’s  p50 is approximately 25 mmHg. Thus, Mb has a greater 
affinity to  O2 than Hb. Therefore, in the presence of normal blood oxygenation in the tissue, Mb is very unlikely 
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to desaturate at resting  conditions10 and it is thus more difficult to investigate in-vivo. However, in skeletal 
muscle Mb is known to desaturate to deoxygenated Mb (dMb) during increased muscle  activity12 and restricted 
blood  flow13. In the myocardium its importance is rather  controversial14–16. Magnetic Resonance Spectroscopy 
(MRS) has been shown to be able to detect different concentrations of dMb in-vivo, however there are no stud-
ies reporting on the BOLD-effect of dMb. Due to the low  p50 of Mb, studies assessing the changes in magnetic 
susceptibility of Mb can only be performed in absence of Hb for validation of this concept. This study aimed to 
assess if Mb has a BOLD-effect that can be detected by clinical cardiovascular magnetic resonance parametric 
mapping sequences.
Results
Presence and patency of myoglobin. Equine metmyoglobin (metMb) powder was dissolved and was 
successfully converted to an oxygenated Mb  (MbO2) solution through auto-oxygenation, shown by light-spec-
troscopy. Half the samples were measured with a standard protein concentration essay, yielding a concentration 
between 4.24 and 4.42 mg/ml after passing the desalting column. Figure 1a. shows the characteristic spectra of 
metMb (stock solution), dMb (after addition of sodium-dithionite) and  MbO2 (after desalting the specimen 
from sodium-dithionite and subsequent auto-oxygenation) in our samples, which are in line with external pub-
lished  findings11. Figure 1b shows that both  MbO2 peaks diminish with decreasing oxygen concentration in the 
plate reader. At 0.4% oxygen concentration the characteristic double-peak spectrum of  MbO2 has vanished, and 
only the single peak spectrum remains, which is characteristic for dMb, demonstrating that no  MbO2 remained 
in these specimens. Increasing ambient oxygen concentration resulted in a recovery of the  MbO2 curve (Fig. 1c).
Imaging results. Twenty-two samples of Mb and twelve samples of Hb from packed red blood cells under-
went MRI imaging. T1, T2, T2* mapping and BOLD-sensitive balanced steady-state free precession (bSSFP) 
Figure 1.  Light spectroscopy of myoglobin oxygenation: (a) Light spectroscopy verified the presence of 
oxygenated myoglobin  (MbO2), by the double peak spectrum (blue) in comparison to deoxygenated myoglobin 
(dMb, purple) and the untreated stock-solution of equine methyl-Mb (metMb, green). (b) Light spectroscopy 
further showed the functional capacity of  MbO2 to desaturate by reducing oxygen concentration from room 
air to 0.4%, and then its ability to re-oxygenate with the increase in oxygen content (c). Image prepared using 
Graphpad Prism v 8.0 (www. graph pad. com).
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cine images were acquired at room air, after deoxygenation by bubbling 100% nitrogen  (N2), reoxygenation by 
bubbling 100% oxygen  (O2) and after chemical reduction to dMb and dHb, respectively, using sodium dith-
ionite. The relative relaxation time and signal intensity changes have been statistically assessed and are shown 
in Fig. 2. In twelve of these Mb and Hb samples, additional images were acquired at 20%, 40%, 60% and 80% 
oxygen concentration for visualization purposes. Due to poor image quality, 1% of the samples could not be 
analyzed for the T1 maps. along with 2% for both the T2 maps and BOLD-bSSFP cine. T2* maps had the poorest 
image quality with an 11% of the levels deemed to be unanalyzable due to artifact. Imaging measurements are 
shown as a response (%-change) in relaxation times and signal intensity from the first level acquired at room air 
(mean ± 95% confidence interval).
T1 and T2 mapping. T1 Mapping revealed that deoxygenating the Mb samples (Fig.  2a) through 
 N2-bubbling increased T1 relaxation time by 24 ± 11% (p < 0.01) over that of the auto-oxygenated state at room 
air. After  O2-bubbling T1 relaxation time dropped down to that of baseline (− 0.6 ± 6%, p > 0.99 vs. baseline, 
p < 0.01 vs. deoxygenation). Similar to the deoxygenated Mb, the chemically reduced Mb solution also increased 
T1 above the room air and reoxygenated states (+ 34 ± 10%, p < 0.01). The Hb response shows a similar trend in 
the curve (Fig. 2e), however only the reoxygenated level showed a significant decrease in T1 in comparison to 
both room air (− 4 ± 3%, p = 0.02) and the deoxygenated state (p = 0.03). Moreover, chemical reduction did not 
impact T1 measurements for the Hb samples (− 1 ± 3%, p > 0.99 vs. room air).
Changing the oxygenation state of the specimens resulted in the opposite effect on transverse (T2) relax-
ation times, when compared to T1 mapping (Fig. 2b,f). T2 mapping of Mb samples showed T2 shortening 
after deoxygenation with  N2 of − 11 ± 7% (p < 0.01), a subsequent prolongation after reoxygenation with  O2 
of + 17 ± 10% (p < 0.01 vs. room air and deoxygenation), and finally the strongest decrease in T2 after reduction 
Figure 2.  MRI detects the changing oxygenation of myoglobin and hemoglobin: Mean ± 95% confidence 
intervals of the percent-change from the room air level are shown for each oxygenation state when measured 
with a T1 map (a, e), a T2 map (b, f), a T2* map (c, g) and a blood oxygen level-dependent balanced steady-state 
free precession image (BOLD-bSSFP; d, h). The responses for isolated myoglobin are shown in the top row and 
red blood cells representing the response of hemoglobin in the bottom row. Dotted lines depict the stepwise 
de-oxygenation process from 100%  O2/0%  N2 to a mix of 0%  O2/100%  N2 in 20% increments. A break is present 
in the negative values of the y-axis to depict the significant reduction by chemical reduction in the same figure. 
Image prepared using Graphpad Prism v 8.0 (www. graph pad. com). *p < 0.05 represents a significant difference 
in signal between major oxygenation levels.
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with sodium-dithionite (− 28 ± 5%, p < 0.01 vs. all levels). With Hb samples, deoxygenation did not alter T2 
relaxation time from room air (− 3 ± 5%, p > 0.99), however reoxygenation significantly increased T2 above the 
room air (11 ± 5%, p = 0.01) and deoxygenated samples (p < 0.01). Chemical reduction had a profound effect, 
decreasing signal to − 82 ± 1% (p < 0.01). Images for the key oxygenation levels can be seen in Fig. 3.
T2* and BOLD‑bSSFP. Deoxygenation by  N2 significantly shortened T2* in Mb samples by − 12 ± 8% 
(p = 0.02, Fig. 2c) from baseline, which then normalized again with reoxygenation (0.3 ± 7%, p > 0.99 vs. baseline, 
p = 0.01 vs. deoxygenation). No changes were observed with the chemical reduction (Fig. 2c). With Hb deoxy-
genation (− 6 ± 4%) shortened T2* as well below both room air (p = 0.04) and reoxygenation (2 ± 3%, p = 0.86 vs. 
room air, p < 0.01 vs. deoxygenation). Similar to T2, chemical reduction strongly reduced T2* in Hb (− 89 ± 1%, 
p < 0.01, Fig. 2g).
Figure 3.  MRI imaging of myoglobin and hemoglobin: Horizontal and vertical cross-section views are shown 
of representative T1 maps, T2 maps, T2* maps and blood oxygen level-dependent balanced steady state free 
precession (BOLD-bSSFP) of red blood cells and dissolved myoglobin in modified test tubes at each major 
oxygenation state. On the left side a hemoglobin sample is shown, while on the right side  a myoglobin sample 
is shown within the same imaging plane and for all acquired imaging sequences, respectively. Image prepared 
using Circle  cvi42 version 5.13 (www. circl ecvi. com).
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Finally using a BOLD-bSSFP, a sequence based on T1 and T2, no changes in signal were observed from room 
air, but chemical reduction (− 3 ± 6%) significantly decreased signal in Mb in comparison to the reoxygenated 
state (p < 0.01, Fig. 2d). In the Hb samples, de-oxygenated blood (− 0.7 ± 1%) did not differ in signal to baseline, 
however reoxygenation (8 ± 6%, p = 0.05 vs. room air) significantly increased the signal above the deoxygenated 
state (p = 0.02). BOLD-bSSFP signal intensity decreased 57 ± 2% with chemical reduction by sodium dithionite 
(p < 0.01, Fig. 2h).
Discussion
BOLD-MRI and Mb-magnetic resonance spectroscopy (Mb-MRS) studies have been performed in humans, 
interrogating the skeletal  muscle13,17–19. While Mb-MRS can specifically interrogate dMb concentration, BOLD-
MRI studies however, were not designed to specifically target Mb. The BOLD-effect of Mb cannot be reliably 
separated from the BOLD-effect of Hb, as long as Hb is present. In this experimental Hb-free in-vitro sample, 
we were able to show that changes in oxygen content in the isolated Mb-specimens led to changes in mapping of 
transverse relaxation times (T2 and T2*), while T1 mapping yielded opposing changes. Additionally, we could 
confirm the known BOLD effects of Hb using modern imaging sequences with this in-vitro system. The observed 
deflections of signal intensities and relaxation times showed the same trajectories in Hb and Mb samples for these 
mapping sequences. It seems thus likely that isolated Mb exhibits a BOLD-effect analogous to Hb.
Light spectroscopy clearly showed distinct optical density spectra of the different Mb species, which are also 
described in other previous  studies11. The following desaturation and resaturation confirmed the functional 
patency of the molecule to bind and release molecular oxygen and it indicated that the preparation process, i.e. 
dissolving, chemical reduction of metMb to dMb and desalting, was successful, leaving auto-oxygenated  MbO2 at 
ambient room air. It is important to stress why an in-vitro approach was utilized to investigate the relaxation time 
and SI changes to different oxygenation states of Mb. Mb has a very low  p50, which allows it to auto-oxygenate, 
even at room air, but this also means it is difficult to desaturate in-vivo unless very extreme physiologic conditions 
 occur11. In skeletal muscle, Mb is prone to desaturate more frequently under exertion training or limited blood 
supply under anaerobe  conditions12,13. In the myocardium,  pO2 levels sufficiently low for Mb desaturation would 
likely result in severe tissue ischemia. In in-vivo imaging exams, the presence of Hb would greatly confound the 
results when trying to interrogate Mb oxygenation with a BOLD-like approach. Indeed, when both species, Hb 
and Mb, are present, we would see decreasing T2 and T2* as a result of deoxygenating Hb when lowering  pO2 
levels, while Mb would remain saturated. Klarhöfer et al. showed decreasing T1 and T2* in skeletal muscle during 
ischemia in human calf muscle at 1.5 T, however this does not discern Hb from Mb  effects19.
Therefore, as a first proof of concept a Hb-free environment was required to establish if there is a BOLD-effect 
for Mb at all. The custom-made sample tubes were sealed to the ambient air with valves to prevent contamination 
with room air and thus auto-oxygenation of Mb and Hb after bubbling with  N2. The increase in T1 mapping after 
bubbling  N2 shows a depletion of freely dissolved  O2. T1 was lower at both oxygenated states, i.e. at room air and 
after bubbling  O2. It is known that molecular oxygen exerts paramagnetic effects on the solvent, which explains 
the decrease in T1 in the oxygenated  state20–22. This, however, is in contrast to the T2 and T2* mapping results. 
In Mb in comparison to reoxygenated states, a decrease in oxygenation resulted in a shortening in T2 and T2*, 
which are susceptible to the paramagnetic effects of dMb. This effect is also known for  Hb2,3 and can be seen in 
the samples containing Hb. In our model, the transition from the diamagnetic  MbO2 to the paramagnetic dMb 
will alter the bulk magnetic susceptibility of the solvent water, which leads to these observed changes in T2 and 
T2*. The paramagnetism of dMb far exceeds that of molecular  O2, which explains why we see these opposing 
effects in longitudinal (T1) in contrast to transverse relaxation (T2 and T2*) measurements, which are known 
to be BOLD-sensitive. The changes in T1, T2 and T2* can also be seen in Hb samples, albeit to a relatively lesser 
extent. There are multiple potential reasons for this attenuation: Firstly, it is known that Hb concentration impacts 
the measured oxygenation response in sequences susceptible to the BOLD-effect23. This is an inherent confounder 
of the measurement technique itself. Secondly, the total oxygen content bubbled through the sample may have 
only been sufficient to oxygenate a fraction of the Hb molecules. Hb molecules consist of a tetramer, while Mb 
is a monomeric compound. Thus, it is expected that more molecular oxygen is required. This could explain the 
attenuated relative increase in T2, T2* and SI in the bSSFP sequence compared to the Mb samples. This is partially 
supported by the diminished increase in T1 in the Hb samples, indicating that there is less chemically dissolved 
oxygen in the sample, as Hb is required to be fully saturated before oxygen will physically dissolve, based on the 
solubility index of oxygen. In addition, the weaker affinity of Hb to oxygen in comparison to Mb could also be 
a reason for the diminished response of Hb samples.
Van den Boomen et al. recently used a combined T2–/T2*-mapping approach over the course of a breath-hold 
to determine the BOLD responses between cardiovascular patients and healthy  controls24. T2* mapping is more 
sensitive to magnetic field inhomogeneities and thus the BOLD-effect than T2 mapping techniques. The same 
applies to T2* versus T2 weighted imaging sequences. The latter employs refocusing pulses in order to correct for 
such field-inhomogeneities, which leads to decreased sensitivity to changes in tissue oxygenation. Importantly, 
T2 mapping is also capable of assessing the oxygenation status of Hb and has thus also a BOLD-effect. Varghese 
et al. used parametric T2 mapping to quantitatively assess blood oxygenation of the left and right  ventricle25. 
Their findings are reflected in our results, where T2 is highly suggestive of a BOLD-like effect for dHb and dMb. 
Although T2* mapping might be more advantageous to measure changes in tissue oxygenation, it is also more 
challenging and our in-vitro results should be interpreted with caution. In our samples, we observed T2* was 
also compromised by the presence of residual gas mix at the top of the bubbling system that created artifacts, 
which were not observed with the other sequences acquired in the same imaging plane. In the heart imaging 
issues with T2* are mostly seen with susceptibility artifacts and lower T2* relaxations times in myocardium at 
the heart lung  interface26,27. Consequently, only the septum is investigated for pathologic T2* relaxation times 
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in clinical scans. T2* mapping, especially at higher field strength, is also much more sensitive to artifacts. This 
could be seen in the higher exclusion rate of T2* maps at 3 T in our experiments. This is why it is currently still 
recommended to be performed only at 1.5 T  clinically27. It is expected that the relative changes in T2* should be 
more pronounced than those of T2 mapping with changing oxygenation states. This is founded by the sensitiv-
ity of local field inhomogeneities in T2* transverse relaxation times in addition to the sensitivity to spin–spin 
interaction in T2  mapping3,27. It would be of interest for future studies to investigate the relationship between 
Mb and T2* imaging at 1.5 T as well.
The BOLD-bSSFP sequence has also been implemented in recent studies to assess the oxygenation response 
of the  myocardium28–30. The observations in our red blood cell samples support the BOLD effect of Hb on bSSFP 
as we observed that oxygenated Hb samples had a higher signal than in images where dHb was deoxygenated 
by either nitrogen gas or chemical reduction. However, we were not able to demonstrate significant changes in 
BOLD-SI of the myoglobin samples between the deoxygenated and oxygenated states, although a detectable drop 
in SI was observed when the sample was reduced with dithionite in comparison to oxygenated level. Balanced 
SSFP sequences show a BOLD-effect, but are characterized by a T2/T1  contrast31. In our study, we saw recipro-
cal changes in T2 versus T1 in the Mb samples, which likely attenuated the changes in overall SI between the 
oxygenation steps for the bSSFP sequence approach. On the other hand, Hb samples did not have a profound T1 
effect, and thus there was less of a competing balance between the T1 and T2 effects and consequently significant 
effects were observed with Hb and T2*.
Mb is known to play a major role in skeletal muscle fibers. Mb with its higher oxygen affinity compared to Hb 
allows the muscle cell to quickly accept the  O2 from the red blood  cells11,15. Thus, its main purpose is to facilitate 
 O2-diffusion32 and  O2  storage33. The striated muscle highly relies on Mb oxygen diffusion and storage in high 
intensity training and in restricted blood  supply12,13. However, the role of Mb in myocardial function is more 
controversial: Mb-deficient knock-out mice showed severe cardiovascular defects in-utero, which resulted in 
 death14. Yet, Mb-deficient knock-out mice that survived showed no significant difference in sarcomere morphol-
ogy and mitochondrial count. However, they showed some cellular and metabolic compensatory mechanisms, 
such as higher capillary density, higher myocardial blood-flow and a higher  hematocrit14,34,35. Endeward et al. 
reported a study, in which their group used a Krogh cylinder model to demonstrate that with a heart rate of 200/
min in humans, the duration of diastole is shortened so that both systole and diastole have the same duration 
(150 ms)15. In this case, it is highly likely that Mb-facilitated  O2-transport secures cellular oxygen supply to the 
left ventricular wall during cessation of blood flow during systole for 22–34  ms16, followed by dependence on the 
 O2-storage function 12–17 ms. If Mb was absent, cellular anoxia would likely occur after 116–99 ms. The authors 
conclude that while Mb plays no role during diastole, in this setting it supplies  O2 to the left ventricular wall for 
up to one third (50 ms) of the 150 ms systole, whereas capillary Hb is responsible for up to 80  ms15. It is important 
to note that Hb will firstly desaturate before Mb can do so. It is clear that approaches exploiting the BOLD-effect 
can detect these changes in Hb desaturation, and this is observed as well in our in-vitro Hb samples with the T2, 
T2* and BOLD-bSSFP images. Our data suggest that the subsequent desaturation of Mb could be detectable as 
well. Importantly, the effects that Endeward et al. reported apply to the healthy human  heart15. Patients with a 
restricted flow reserve or in other pathologies in which oxygen demand may outweigh the supply, i.e. coronary 
artery disease, heart failure, hypertrophic cardiomyopathies, it can be expected that this effect may in fact occur 
at much lower heart rates, when patients feel exertion. Guensch et al. showed in a swine model that BOLD-SI 
only drops when oxygen demand outweighs the  supply36. In patients with cardiovascular disease, this balance 
may be much more delicate and shifted, with fewer reserves on the supply side. However, previous publications 
were not designed to show Mb-specific effects. Recent cardiovascular MR studies used BOLD-sensitive cines 
that have sufficient temporal resolution to detect oxygenation deficits in systolic and diastolic cardiac phases to 
test such a theoretical paradigm postulated by Endeward and  colleagues15. It remains to be seen if BOLD-MRI 
measurements targeting Mb saturation as the ultimate tissue oxygenation marker will have a potential clinical 
role in the future. Such studies could distinguish a decrease in extracellular oxygenation reserve driven by Hb 
deoxygenation from genuine tissue ischemia driven by intracellular depletion of Mb oxygen stores. This may 
serve as a future severity marker for ischemic heart disease. This concept would however require further experi-
mental validation in muscle samples and eventual in-vivo studies.
The proportional role of Mb and Hb may also depend on the amount of protein in the imaging plane. Our 
in-vitro results are depicted as a %-change from the room air level to account for differences in concentration 
of the Mb and Hb proteins in each sample. In an in-vivo environment, the concentration of these proteins in an 
imaging plane will vary as well. In a study by Guensch et al. the authors showed that lowering the Hb concen-
tration in-vivo increases baseline SI and attenuated the oxygenation response exploited induced by vasoactive 
 stimuli23. Myoglobin is present in skeletal muscle at approximately 400–500 µmol/kg of wet mass tissue and at 
about 200–300 µmol/kg in myocardial  tissue37. With a molar mass of 17,600 g/mol, the equine Mb used in this 
study is equivalent to the human Mb  protein37. While muscle density differs on the muscle and patient health, 
generally skeletal and myocardial muscle have a density around 1.055 g/ml, which yields an approximate con-
centration range of 6.67–8.34 mg/ml of myoglobin protein content in skeletal muscle and 3.22–5.00 mg/ml in 
the myocardium. In our samples, the measured Mb concentration ranged from 4.24 to 4.42 mg/ml and is in 
line with the expected concentration in the myocardium. While Mb is primarily fixed in the muscle, it does 
circulate in the blood bound to plasma globulins, but at a minimal level (< 0.03 mg/ml)38. Mb can be released 
in higher concentrations due to muscle injury. Stone et al. reported a mean serum Mb of 528 ± 76 ng/ml after 
acute myocardial  infarction39, while Wasfie et al. showed Mb can increase further in trauma patients with a high 
injury severity score reporting a maximum measured value of 11,197 ng/ml40. It is unknown how this would 
impact MRI signal and relaxation as the concentration of serum Mb is still relatively low in comparison to the 
Mb content of the muscle and to hemoglobin. And due to its higher affinity to oxygen, it is unlikely to desaturate 
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in the blood stream, not even in venous blood. Thus, released serum Mb is unlikely to confound studies exploit-
ing the BOLD-effect of Hb.
We used a Hb concentration between 10.0 and 11.0 g/dl, which is slightly lower than the general human refer-
ence ranges for arterial blood (12.0–18.0 g/dl). However, in an in vivo model the local Hb content in the imaging 
plane can fluctuate based on arteriolar vasodilation and capillary recruitment throughout the tissue. Capillaries, 
in particular, are the vessels that contain the majority of blood volume and dHb and thus have a high impact on 
the BOLD  effect9. In addition, as the Hb molecules were inside intact red blood cells, a certain degree of sedi-
mentation may occur. However, this may have only played a minor role, as the red blood cells would have been 
mobilized through the bubbling process and image acquisition took place within a couple minutes, before the 
next bubbling occurred. Thus, significant sedimentation is unlikely and was not visually observed in the samples.
There are limitations associated with this work. This proof of concept required an experimental in-vitro 
model, where no confounding Hb was present, therefore we chose to use lyophilized equine Mb powder. This 
model possesses both, strengths and weaknesses: first, by lacking other cellular proteins that may exert paramag-
netic effects as well, we can be sure that the observed effects result from Mb oxygenation changes alone. How-
ever, these conditions make it harder to be translated into a cellular in-vitro and in-vivo environment. Nor can 
these isolated measurements determine how much Mb will contribute to the BOLD effect in an in-vivo model. 
As observed in the red blood cell samples, chemical reduction by sodium dithionite resulted in a significantly 
reduced signal beyond that observed in Mb. Moreover, a significant difference between the in-vitro and in-vivo 
environments is that the in-vivo myocardial oxygenation balance is influenced by perfusion changes and oxygen 
consumption of the tissue, whereas our in-vitro assessments do not incorporate these factors. Increased tissue 
perfusion will result in an increased MRI signal in BOLD-sensitive approaches due to a higher blood volume 
increasing the local content of bulk water and due to an increased oxygen supply to the tissue, resulting in the 
oxygenation of Mb and Hb and the washing out of dHb. Rather, the in-vitro assessments simplify the BOLD 
response by eliminating potential confounders based on physiologic responses and demonstrate if the paramag-
netic properties of these compounds do impact MRI signal based on the oxygenation changes alone. A direct 
comparison of our measurements with Mb-MRS would have strengthened our model. Unfortunately, MRS was 
not available. However, since there was no other molecule in this in-vitro model, and desaturation during light 
spectroscopy verified desaturation, it is very suggestive that bubbling 50 ml of 100%  N2 through a 5 ml sample 
voided the sample of oxygen and induced Mb desaturation. It was not possible to determine the oxygen saturation 
of Mb and Hb or partial pressure of oxygen  pO2 with a blood gas analyzer because obtaining the sample would 
have causes air contamination, resulting in auto-oxygenation of Mb and falsely high  pO2. T2* mapping showed 
the same trends as T2 mapping with Mb oxygenation changes. We would have expected the changes in T2* to 
be more pronounced. The fact that T2 mapping also showed the BOLD-effect for Mb with much better image 
quality makes this approach a better candidate for assessing Mb oxygenation changes at 3 T than T2* mapping. 
In the future the same measurement should be performed with different Mb concentrations and oxygenation 
states to further corroborate our findings. In a study assessing different Hb concentrations in-vivo, it has been 
shown that hemodilution has profound effects on BOLD-CMR  measurements23.
Our data demonstrate that T2 and T2*-shortening after deoxygenation of in-vitro Mb specimens, which is 
highly suggestive of a BOLD-like effect, similar to that of Hb in red blood cells. The changes in oxygen con-
centration in the samples are supported by inverse changes in T1 mapping. Further studies are warranted and 
required to corroborate this concept, to assess the overall contribution of Mb, and to determine if a potential 
clinical utility exists for Mb.
Methods
Myoglobin preparation. Commercially available lyophilized equine metmyoglobin (metMb) powder 
(Sigma-Aldrich, St. Louis, USA) was dissolved in PBS-buffer to yield a concentration of 20 mg/mL (Supplemen-
tal Figure 1). MetMb, myoglobin with Iron(III), does not bind  oxygen41. Therefore, samples were reduced by 
addition of sodium-dithionite to dMb, now containing Iron(II). Sodium-dithionite will result in a reduction of 
pH, thus pH was adjusted to 7.35–7.45 to ensure normal function of Mb. As dMb cannot oxygenate in the pres-
ence of residual sodium-dithionite ions, the excess sodium-dithionite was removed from solution with a separa-
tion column (GE Healthcare HiPrep 26/10 Desalting column, GE Health Care, Chicago, USA) according to the 
vendor’s directions and as published  before11. This allowed for auto-oxygenation of Mb at room air  (MbO2) due 
to the very low  p50. During the desalting process aliquots were sampled every 30 s, which were then interrogated 
with light-spectroscopy for the presence of dMb and thus residual sodium-dithionite (Fig. 4). Samples with pure 
 MbO2 was used for further analyses and samples with dMb were discarded due to high probability of residual 
sodium dithionite.
Analysis for functional myoglobin patency. In the next step the functional capability of Mb molecules 
was interrogated, verifying  MbO2 could desaturate to dMb by depriving the samples from oxygen  (O2). The 
 MbO2 samples were pipetted into the wells of a microplate reader for light spectroscopy (Tecan Infinite 200 
Pro, Tecan Group Ltd, Switzerland). Optical density (OD) was measured in 10 nm increments between 500 and 
700 nm wavelengths. This was performed at room air (20%  O2) and repeated at 15%, 10%, 5% and finally 0.4% 
environmental oxygen in the plate reader. The remainder of the partial pressure was driven by supplemental 
nitrogen  (N2). Thereafter, oxygen concentration was restored in reverse steps.
Hemoglobin preparation. Hb was assessed with the use of blood samples. Human packed red blood cells, 
which were not to be used in recipients anymore, were acquired from the central blood lab at the institute and 
diluted by a factor of two with saline to achieve a Hb concentration between 100 and 110 g/L.
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Imaging and analysis. The Mb and Hb samples were then transferred in custom-made 5 ml compartments 
that were sealed off by inlet and outlet valves for bubbling gases through the samples and allow for pressure 
equalization. An additional Luer-Lock hub was used to bubble nitrogen  (N2) and oxygen  (O2) through the sam-
ples and to add sodium-dithionite to conclude the experiments. All samples were scanned submerged in a water 
bath at room temperature and were imaged with a 20-channel head coil in a 3 T MAGNETOM Prisma Fit (Sie-
mens Healthineers, Erlangen, Germany). Clinical sequences from the cardiac package were used and modified 
to obtain a higher spatial resolution. Images were triggered with a simulated heart rhythm with an RR interval 
of 1200 ms. Imaging parameters can be found in Table 1. At room air, T1, T2 and T2* maps along with BOLD-
bSSFP images were scanned in an axial cross-section and vertical long-axis view of the specimen compartment. 
The same images were obtained at each level after the bubbling process had been completed. First a step-wise 
deoxygenation was performed by bubbling a mix of  O2 and  N2 through the specimen over 2 min. This was per-
formed in 20% increments starting with (1) 0%  N2/100%  O2; (2) then 20%  N2/80%  O2; (3) 40%  N2/60%  O2; (4) 
60%  N2/40%  O2; (5) 80%  N2/20%  O2; and (6) 100%  N2 to obtain full deoxygenation. Afterwards samples were 
reoxygenated by bubbling 50 ml 100%  O2 and finally chemically reduced by adding sodium-dithionite. Twelve 
Mb and Hb samples were imaged at all levels, with an additional ten Mb samples acquired at the key stages: room 
air, deoxygenation (100%  N2), re-oxygenation (100%  O2) and chemical reduction.
Images were analyzed with clinically validated software,  cvi42 (Circle Cardiovascular Imaging Inc, Calgary, 
Alberta, Canada). For all images, regions of interest (ROI) were traced in the axial cross-section of a sample 
carefully avoiding artifact at the border of the compartments (Supplemental Figure 2). ROI were then copied 
and forwarded to remaining levels to ensure the same positioning and adjusted in cases of where the sample 
position had shifted. In the case of poor image quality, contours were also drawn in the vertical long-axis view 
and the data was then averaged.
Statistical analysis. To account for different concentrations and thus baseline signal, data are shown as a 
%-change in signal from the first level acquired at room air (mean ± 95% confidence intervals). Measurements 
were statistically compared between the key oxygenation states (room air; deoxygenation with 100%  N2; re-oxy-
genation with 100%  O2; and chemical reduction) for both Mb and Hb with a mixed effects linear model. Bonfer-
roni’s multiple comparisons tests were performed after, if applicable. Statistical results were regarded significant 
Figure 4.  Experimental Procedure: (1) Equine metmyoglobin (metMb) was first reduced to deoxymyoglobin 
(dMb) and desalted to gain oxygenated myoglobin  (MbO2) by auto-oxygenation, (2) after which samples were 
verified with light spectroscopy during decreasing then increasing oxygen concentrations. (3) Myoglobin 
solution and packed red blood cells were then placed into sealed compartments designed for gas bubbling. MRI 
was performed with four sequences in a vertical view, and one horizontal cross-section view under conditions 
designed to oxygenate and de-oxygenate myoglobin (Mb) and hemoglobin (Hb).
Table 1.  Imaging parameters. FOV: Field of View, TE: Echo time, TR: Temporal Resolution.
Sequence T1 Map T2 Map T2* Map BOLD-bSSFP
Voxel  (mm3) 0.5 × 0.5 x 5.0 0.6 × 0.6 x 5.0 0.5 × 0.5 x 5.0 0.7 × 0.7 x 0.5
FOV (mm) 250 × 250 223 × 178 215 × 215 267 × 267
TE/TR (ms) 1.58/3.6 1.58/3.7 */19.0 1.93/3.9
Flipangle (°) 35 12 15 35
Bandwidth (Hz/Px) 977 1184 503 1302
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with a two-sided p < 0.05. For light-spectroscopy, only qualitative assessments were performed. GraphPad Prism 
version 8.0 (GraphPad Software, La Jolla California USA) was used for statistical analysis.
The datasets generated during the current study are available from the corresponding author on reasonable 
request.
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